Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001776985-24-000040
Filing Date
2024-05-06
Accepted
2024-05-06 07:18:26
Documents
5
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K form6-kq12024quarterlyrepo.htm 6-K 13634
2 EX-99.1 bnt_2024q1ex99x1quarterlyr.htm EX-99.1 1631997
3 a230530_ihub-labxshootingx.jpg GRAPHIC 1012449
4 image_0.jpg GRAPHIC 3862
5 test.jpg GRAPHIC 8957
  Complete submission text file 0001776985-24-000040.txt   3058845
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 24915540
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)